Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225116084> ?p ?o ?g. }
- W4225116084 abstract "Since their introduction as antidiabetic drugs, SGLT2 inhibitors (SGLT2i) have come a long way, proving to be beneficial on cardiovascular and renal outcomes independently of diabetes status. The benefits go far beyond glycemic control, and both the cardio- and nephroprotection are underpinned by diverse mechanisms. From the activation of tubule glomerular feedback and the consequent reduction in hyperfiltration to the improvement of hypoxia and oxidative stress in the renal cortex, SGLT2i have also been shown to inhibit hepcidin and limit podocyte damage. Likewise, they improve cardiac metabolism and bioenergetics, and reduce necrosis and cardiac fibrosis and the production of adipokines, cytokines, and epicardial adipose tissue mass. In terms of outcomes, the efficacy has been demonstrated on blood pressure control, BMI, albuminuria, stroke, heart disease, and mortality rate due to cardiovascular events. Patients with chronic kidney disease and proteinuria, with or without diabetes, treated with some SGLT2i have a reduced risk of progression. The analysis of subgroups of individuals with specific diseases such as IgA nephropathy has confirmed this solid effect on renal outcomes. Given these overarching activities on such a broad pathophysiological background and the favorable safety profile that goes with the use of SGLT2i, it is now certain that they are changing our approach to clinical interventions for important outcomes with an impressive impact." @default.
- W4225116084 created "2022-05-01" @default.
- W4225116084 creator A5001391327 @default.
- W4225116084 creator A5003364015 @default.
- W4225116084 creator A5044069341 @default.
- W4225116084 creator A5045326915 @default.
- W4225116084 creator A5047264159 @default.
- W4225116084 creator A5049795076 @default.
- W4225116084 creator A5056089291 @default.
- W4225116084 creator A5059086195 @default.
- W4225116084 creator A5061060122 @default.
- W4225116084 creator A5075572425 @default.
- W4225116084 creator A5087064757 @default.
- W4225116084 date "2022-04-29" @default.
- W4225116084 modified "2023-09-26" @default.
- W4225116084 title "SGLT2 Inhibitors: A Broad Impact Therapeutic Option for the Nephrologist" @default.
- W4225116084 cites W175419662 @default.
- W4225116084 cites W1969716641 @default.
- W4225116084 cites W1973038508 @default.
- W4225116084 cites W1993014774 @default.
- W4225116084 cites W1999553053 @default.
- W4225116084 cites W2023635287 @default.
- W4225116084 cites W2026412750 @default.
- W4225116084 cites W2038961968 @default.
- W4225116084 cites W2067775744 @default.
- W4225116084 cites W2072040765 @default.
- W4225116084 cites W2087879109 @default.
- W4225116084 cites W2100796772 @default.
- W4225116084 cites W2105660444 @default.
- W4225116084 cites W2106825405 @default.
- W4225116084 cites W2125065061 @default.
- W4225116084 cites W2126463670 @default.
- W4225116084 cites W2130348707 @default.
- W4225116084 cites W2131411448 @default.
- W4225116084 cites W2133507189 @default.
- W4225116084 cites W2141023837 @default.
- W4225116084 cites W2141495158 @default.
- W4225116084 cites W2143580981 @default.
- W4225116084 cites W2146264128 @default.
- W4225116084 cites W2146702281 @default.
- W4225116084 cites W2151345870 @default.
- W4225116084 cites W2153839551 @default.
- W4225116084 cites W2166613497 @default.
- W4225116084 cites W2169403426 @default.
- W4225116084 cites W2170276146 @default.
- W4225116084 cites W2171294019 @default.
- W4225116084 cites W2311822206 @default.
- W4225116084 cites W2319556354 @default.
- W4225116084 cites W2329850142 @default.
- W4225116084 cites W2341611738 @default.
- W4225116084 cites W2512006388 @default.
- W4225116084 cites W2532735232 @default.
- W4225116084 cites W2560643142 @default.
- W4225116084 cites W2588592529 @default.
- W4225116084 cites W2591986567 @default.
- W4225116084 cites W2594630750 @default.
- W4225116084 cites W2615714795 @default.
- W4225116084 cites W2622688333 @default.
- W4225116084 cites W2626446274 @default.
- W4225116084 cites W2739456155 @default.
- W4225116084 cites W2742198484 @default.
- W4225116084 cites W2763866789 @default.
- W4225116084 cites W2764144227 @default.
- W4225116084 cites W2772204795 @default.
- W4225116084 cites W2781483265 @default.
- W4225116084 cites W2782103987 @default.
- W4225116084 cites W2790579026 @default.
- W4225116084 cites W2809670704 @default.
- W4225116084 cites W2884466498 @default.
- W4225116084 cites W2884817413 @default.
- W4225116084 cites W2887628755 @default.
- W4225116084 cites W2892823508 @default.
- W4225116084 cites W2899764361 @default.
- W4225116084 cites W2900413769 @default.
- W4225116084 cites W2903192033 @default.
- W4225116084 cites W2904387867 @default.
- W4225116084 cites W2907458346 @default.
- W4225116084 cites W2910145779 @default.
- W4225116084 cites W2914038117 @default.
- W4225116084 cites W2929633637 @default.
- W4225116084 cites W2939222610 @default.
- W4225116084 cites W2944135920 @default.
- W4225116084 cites W2944717765 @default.
- W4225116084 cites W2947062659 @default.
- W4225116084 cites W2948866758 @default.
- W4225116084 cites W2964932552 @default.
- W4225116084 cites W2965578843 @default.
- W4225116084 cites W2974260792 @default.
- W4225116084 cites W2979968423 @default.
- W4225116084 cites W3003901753 @default.
- W4225116084 cites W3005610359 @default.
- W4225116084 cites W3025899746 @default.
- W4225116084 cites W3027707577 @default.
- W4225116084 cites W3035468154 @default.
- W4225116084 cites W3080572896 @default.
- W4225116084 cites W3080595426 @default.
- W4225116084 cites W3081830235 @default.
- W4225116084 cites W3082758064 @default.
- W4225116084 cites W3086985336 @default.
- W4225116084 cites W3088173406 @default.